Boris Pasche, MD, PhD, FACP, President and Chief Executive Officer of Barbara Ann Karmanos Cancer Institute and Oncology Department Chair at Wayne State University
Becker’s Healthcare PodcastSummary
Dr. Boris Pash, President and CEO of the Barbara Ann Karmanos Cancer Institute, shares insights into the institute's recent accomplishments and future goals. This year marks a significant milestone as Karmanos submitted its renewal application to maintain its status as a comprehensive cancer center, a process that occurs every five years for National Cancer Institute-designated centers. The application, submitted in January, highlights the institute's achievements in clinical trials, community outreach, and education. Following a successful site visit, the institute anticipates feedback from the NCI later this year regarding continued funding.
Dr. Pash discusses the challenges faced by the academic community due to changes in federal funding and policies, particularly under the new administration. However, he notes a recent bipartisan consensus in Congress supporting cancer research, which has alleviated some anxiety among faculty. He emphasizes the importance of adapting to new developments in cancer treatment, such as the promising results of daratumumab for pancreatic cancer, which has shown significant efficacy in shrinking tumors and extending patient survival.
Looking ahead, Dr. Pash underscores the need for cancer centers to remain agile in response to evolving therapies and patient care models. He highlights the importance of providing access to advanced treatments across Karmanos' extensive network of facilities in Michigan, ensuring that patients in both urban and rural areas receive the best possible care. He concludes by reflecting on the qualities of effective leadership, drawing inspiration from visionaries across various industries who have successfully implemented innovative ideas.
Show Notes
In this episode, Boris Pasche, MD, PhD, FACP, President and Chief Executive Officer of Barbara Ann Karmanos Cancer Institute and Oncology Department Chair at Wayne State University, joins the podcast to discuss navigating uncertainty in today’s healthcare environment. He shares insights on evolving therapy services and highlights emerging breakthroughs in oncology that are shaping the future of cancer care.
More from Becker’s Healthcare Podcast
In this episode, Ryan Mezinger, Senior Vice President and Chief Pharmacy Officer at MetroHealth, and Dr. Amit Gir, CEO and Co-Founder of Phox Health, discuss how MetroHealth's pharmacy delivery model is improving medication access, adherence, patient satisfaction, and care continuity while strengthening chain of custody and pharmacy operations.
In this episode, Dr. Kyle W. Trecartin, Chief Medical Officer, Beth Israel Deaconess Hospital - Plymouth, discusses improving patient throughput, strengthening quality and safety through a just culture, and expanding access to care in the community.
In this episode, Erica Rowe Urquhart, MD, PhD, Orthopedic Surgeon, Author, Healthcare Thought Leader, discusses how reimbursement pressures shape independent medical practices, why physicians must understand healthcare finance, and the leadership skills needed to sustain quality patient care.
In this episode, Dr. Sanjiv Shah, Chief Medical Officer, MetroPlusHealth, discusses how care management, provider partnerships, and timely information exchange have helped MetroPlusHealth earn consecutive four star Medicare Advantage ratings. He also shares strategies for closing care gaps, improving transitions after hospital stays, and preparing providers for digital quality reporting requirements.
In this episode, Dr. Alice Chen, Chief Health Officer at Centene, discusses how health plans can use evidence based prevention frameworks to improve outcomes, guide investments, and reduce waste. She shares lessons from food as medicine initiatives and explains why interventions must be supported by rigorous data, tailored to underserved populations, and proven effective before scaling.